Linked here is a detailed quantitative analysis of Johnson & Johnson (JNJ). Below are some highlights from the above linked analysis: Company Description: Johnson & Johnson is a leader in the pharmaceutical, medical device, and …
Johnson & Johnson (ticker: JNJ) has largely lied low in an otherwise contentious year for large name-brand U.S.-based companies. With big oil companies fighting falling prices, big auto and manufacturing firms answering to an "America …
Johnson & Johnson (NYSE: JNJ) stock first traded back in 1944. For the first 58 years of the company's existence, it was privately held by the Johnson family. J&J stock has been a big winner throughout the years, but never more so …
Johnson & Johnson (NYSE:JNJ) is an old stalwart, known for being one of the most reliable stocks for dividend investors. It is among an elite class of companies that have increased their dividend payouts every year for at least 25 years. …
Johnson & Johnson (NYSE: NYSE:JNJ) is a $358 billion company today. Investors that bought shares one year ago are sitting on a 10.56% total return. That's below the S&P 500's return of 16.05%. Johnson & Johnson stock is …
Drugmaker Johnson & Johnson (NYSE: JNJ) announced a $10 billion stock buyback program today (Tuesday) amid a mixed Q3 earnings report. The $10 billion JNJ stock buyback represents about 3.7% of the company's outstanding …
If you’re looking for a textbook example of a steady rise in shares, it doesn’t get much better than the current Johnson & Johnson (NYSE:JNJ) stock run-up. Shares in the blue-chip company are up 15% year-to-date with a nice upward …
Linked here is a detailed quantitative analysis of Johnson & Johnson (JNJ). Below are some highlights from the above linked analysis: Company Description: Johnson & Johnson is a leader in the pharmaceutical, medical device and …